TAMPA, Fla.--(BUSINESS WIRE)--Xcelience, a leader in early drug contract development, has expanded formulation development and manufacturing capabilities to include a Piccola B10 Minipress. This 10-station table top rotary tablet press enables clients to make an early assessment of how the developed process and formula will perform in production, which can shorten development time and lead to early identification and resolution of potential formulation issues. The ability to cost-effectively produce small batch sizes in the experimental area while obtaining all of the necessary processing parameters is an additional advantage.
